The Vitamin E market in the United States extended its downtrend through February as muted demand and limited seasonal uplift softened activity. Early-month trading was balanced and range-bound, while mid-month procurement failed to generate momentum. Sellers conceded FOB levels amid broad weakness across end-use channels, prolonging a pronounced bearish pattern. Demand across tracked sectors deteriorated, with offtake and seasonal pull-through described as muted, pressuring seller pricing discipline. Supply-side dynamics offered little relief, as raw-material flow, logistics, inventory, energy costs, and labor remained steady with no disruptions, allowing producers to maintain output but without a demand backstop. Producers were reportedly willing to trim FOB offers to sustain plant utilization; the February reference sat in the low-to-mid range for market pricing. Weekly assessments show ongoing softness into late February, with no uptick in end-use demand. Outlook remains tilted to the downside absent a demand revival or unexpected logistic constraints, suggesting additional pressure next week. However, longer-term cost dynamics may shift. The ongoing conflict involving the United States, Israel, and Iran is likely to exert upward pressure on global crude oil prices, which could subsequently increase energy and transportation costs. Higher freight rates, particularly for bulk and container shipments, may further elevate input and distribution expenses across the supply chain.
